Drugs / THC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05322213 Comparator | Aug 2024 → Dec 2027 expected | type 2 diabetes mellitus | University of California, San Diego | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | THC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05322213 ↗ |
| Route | Inhaled | “inhaled THC” NCT05322213 ↗ |